Amedisys, Inc. (AMED) reported adjusted earnings per share (EPS) of $1.00 in the third quarter of 2024, up 2% year over year. However, the metric missed the Zacks Consensus Estimate by 12.3%.The quarter’s adjustments include certain merger-related expenses and other (income)/expenses, net.GAAP EPS was 51 cents compared with 79 cents in the corresponding period of 2023.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement, AMED’s shares lost 0.1% to reach ...